beta-Adrenergic stimulation reduces albumin permeation across pulmonar
y artery endothelial monolayers and induces changes in cell morphology
that are mediated by Cl- flux. We tested the hypothesis that anion-me
diated changes in endothelial cells result in changes in endothelial p
ermeability. We measured permeation of radiolabeled albumin across bov
ine pulmonary arterial endothelial monolayers when the extracellular a
nion was Cl-, Br-, I-, F-, acetate (Ac-), gluconate (G(-)), and propio
nate (Pr-). Permeability to albumin (P-albumin) was calculated before
and after addition of 0.2 mM of the phosphodiesterase inhibitor 3-isob
utyl-1-methylxanthine (IBMX), which reduces permeability. In Cl-, the
P-albumin was 3.05 +/- 0.86 x 10(-6) cm/s and fell by 70% with the add
ition of IBMX. The initial P-albumin was lowest for Pr- and Ac-. Initi
al P-albumin was higher in Br-, I-, G(-), and F- than in Cl-. A permea
bility ratio was calculated to examine the IBMX, effect. The greatest
IBMX effect was seen when Cl- was the extracellular anion, and the ord
er among halide anions was Cl- > Br- > I- > F-. Although the level of
extracellular Ca2+ concentration ([Ca2+](o)) varied over a wide range
in the anion solutions, [Ca2+](o) did not systematically affect endoth
elial permeability in this system. When Cl- was the extracellular anio
n, varying [Ca2+](o) from 0.2 to 2.8 mM caused a change in initial P-a
lbumin but no change in the IBMX effect. The anion channel blockers ac
etamido-4'-isothiocyanotostilbene-2,2-disulfonic acid (0.25 mM) and an
thracene-9-carboxylic acid (0.5 mM significantly altered initial P-alb
umin and the IBMX effect. The anion transport blockers bumetanide (0.2
mM) and furosemide (1 mM) had no such effects. We conclude that extra
cellular anions influence bovine pulmonary arterial endothelial permea
bility and that the pharmacological profile fits better with the activ
ity of anion channels than with other anion transport processes.